Related Experiment Video
Updated: Apr 2, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
A novel delivery platform based on Bacteriophage MS2 virus-like particles
Yu Fu1, Jinming Li2
1National Center for Clinical Laboratories, Beijing Hospital, Beijing 100029, China; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, China; Departments of Nuclear Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Bacteriophage MS2 virus-like particles (VLPs) are novel nanoparticles ideal for targeted delivery of therapeutic agents. These versatile VLPs show significant promise for applications in diagnostics, vaccines, and advanced medical treatments.
Area of Science:
- Nanotechnology and Virology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Bacteriophage MS2 virus-like particles (VLPs) are protein-based nanoparticles.
- These VLPs are self-assembled structures derived from the MS2 bacteriophage coat protein.
- VLPs are devoid of viral genetic material, ensuring safety for therapeutic applications.
Purpose of the Study:
- To review the novel delivery platform based on Bacteriophage MS2 virus-like particles (VLPs).
- To introduce the structure and potential of MS2 VLPs as a delivery system.
- To explore their expected applications in medicine and other fields.
Main Methods:
- Review of existing literature on Bacteriophage MS2 virus-like particles (VLPs).
- Analysis of VLP structure and self-assembly properties.
- Evaluation of VLP suitability for targeted delivery of various payloads.
Main Results:
- MS2 VLPs exhibit an icosahedral capsid structure.
- Their protein capsid can encapsulate diverse molecules like RNAs, DNAs, peptides, and drugs.
- VLPs demonstrate suitability for targeted delivery due to their nanoparticle nature.
Conclusions:
- Bacteriophage MS2 VLPs represent a promising novel delivery platform.
- They offer attractive features for the targeted delivery of therapeutic agents.
- MS2 VLPs hold significant potential for use in diagnostics, vaccines, and therapeutic modalities.
More Related Videos
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
08:14Analysis of the Solvent Accessibility of Cysteine Residues on Maize rayado fino virus Virus-like Particles Produced in Nicotiana benthamiana Plants and Cross-linking of Peptides to VLPs
Published on: February 14, 2013
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Viruses with RNA Genomes
Viral Replication: Lytic Cycle
Lysogenic Cycle of Bacteriophages
Subviral Agents